Understanding how brain cells called microglia repair damage in Alzheimer's disease
Na/H Exchanger in Microglial Metabolism and Function
This project explores how a specific protein in brain cells called microglia helps them clean up debris and repair damage in conditions like Alzheimer's disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11141690 on NIH RePORTER |
What this research studies
Our brain contains special immune cells called microglia that are crucial for cleaning up damaged tissue and helping the brain recover from injury or disease. This work focuses on a protein called NHE1 within these microglia, which appears to control how these cells get energy and perform their cleanup duties. By understanding how NHE1 influences microglial activity, we hope to find new ways to encourage these cells to better repair brain damage in conditions such as Alzheimer's disease. We are observing how changes to this protein affect microglial behavior and their ability to clear harmful substances.
Who could benefit from this research
Good fit: This foundational research is for patients with neurodegenerative conditions, particularly Alzheimer's disease, who might benefit from future therapies targeting brain repair.
Not a fit: Patients seeking immediate treatment options would not directly benefit from this early-stage laboratory research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that enhance the brain's natural repair processes in neurodegenerative diseases like Alzheimer's.
How similar studies have performed: While the specific mechanisms of NHE1 in microglial immunometabolism are being newly explored, the importance of microglial function in neurodegenerative diseases is well-established.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Sun, Dandan — University of Pittsburgh at Pittsburgh
- Study coordinator: Sun, Dandan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.